Possible association of venous thromboembolism and hyperthyroidism: 4 case reports and literature review

New Zealand Medical Journal

Volumn 121, Issue 1280, 2008, Pages 53-57

  Kim, David D W ^a   Young, Simon ^a   Chunilal, Sanjeev ^a   Cutfield, Rick ^a  

^a NORTH SHORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; CARBIMAZOLE; D DIMER; PHENYTOIN; PREDNISONE; RADIOACTIVE IODINE; TECHNETIUM 99M; THYROXINE; WARFARIN; ANTITHROMBIN; ANTITHYROID AGENT; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; ORAL CONTRACEPTIVE AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CARDIOVERSION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GRAVES DISEASE; HEADACHE; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LETHARGY; LUNG EMBOLISM; MALE; NAUSEA AND VOMITING; NEW ZEALAND; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA EFFUSION; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; RADIOFREQUENCY ABLATION; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TACHYPNEA; TEMPORAL LOBE; THORAX PAIN; THORAX RADIOGRAPHY; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROTOXICOSIS; TONIC CLONIC SEIZURE; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; GENETICS; LETTER; MIDDLE AGED; MUTATION; RISK FACTOR;

ADULT; ANTICOAGULANTS; ANTITHROMBINS; ANTITHYROID AGENTS; CARBIMAZOLE; CONTRACEPTIVES, ORAL, COMBINED; FACTOR V; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; MUTATION; RISK FACTORS; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 53449084417     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Squizzato A, Romualdi E, Buller HR, Gerdes VE. Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review. J Clin Endocrinol Metab. 2007;92:2415-20.
2. Homoncik M, Gessl A, Ferlitsch A, et al. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 2007;92:3006-12.
3. Erem C, Ersoz HO, Karti SS, et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest. 2002;25:345-50.
4. Verberne HJ, Fliers E, Prummel MF et al. Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid. 2000;10:607-10.
5. Nagumo K, Fukushima T, Takahashi H et al. Thyroid crisis and protein C deficiency in a case of superior sagittal sinus thrombosis. Brain Nerve. 2007;59:271-6.
6. Koster T, Blann AD, Briet E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152-5.
7. Kyrle PA, Minar E, Hirschl M, et at. High plasma levels of Factor VIII and the risk of recurrent venous thromboembolism. N Eng J Med. 2000;343:457-62.
8. Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med. 1982;97:713-6.
9. Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid. 2001;11:153-60.
10. Nossent AY, Van Marion V, Van Tiltburg NH, et al. von Willebrand factor and its propeptide: The influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost. 2006;4:2556-62.
11. Weltermann A, Eichinger S, Bialonczyk C, et al. The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost. 2003;1:28-32.